A blood draw at a family doctor’s office can now detect Alzheimer’s disease pathology with accuracy that rivals the work of ...

New biomarker tests can help prevent devastating misdiagnoses. Beacon Hill should ensure that every patient can access them.

Some Alzheimer’s blood tests are now FDA approved for early detection of the disease, but not everyone is a candidate. Here’s what determines whether you qualify and how doctors decide. What Group ...

Just like we do for our hearts and our bodies, we need to have a multimodal approach to risk reduction of brain disease.” ...

Nearly 7 million Americans are living with Alzheimer’s disease and that number is projected to rise to nearly 13 million.

Blood-based testing sidesteps much of that. The tests measure proteins in a routine blood sample that correlate with the presence of amyloid plaques or tau tangles, the two hallmarks of Alzheimer’s ...

By bringing Alzheimer’s blood-based biomarker testing into primary care, we can help patients and their clinicians get answers sooner.” ...

Alzheimer's research is moving in new directions, finding ways to make testing much more accessible, and offering more ...

New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of ...

Research presented this week at the Alzheimer’s Association International Conference in London suggests that the use of blood ...

‘There are actually more than 100 different types of dementia,’ says Prof Crutch - Paul Grover Most people think of dementia as a condition affecting memory and older people, but in 15 per cent of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Diagram of a lumbar puncture procedure to collect cerebrospinal fluid. A needle is gently ...